Wall Street Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Wall Street Associates’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-21,850	Closed	-$1.26M	–	326
2015 Q2	$1.26M	Sell	21,850 -6,200	-22%	-$394K	0.12%	182
2015 Q1	$1.79M	Sell	28,050 -11,765	-30%	-$798K	0.17%	154
2014 Q4	$2.46M	Buy	39,815 +13,243	+50%	+$653K	0.24%	128
2014 Q3	$1.03M	Sell	26,572 -5,600	-17%	-$198K	0.11%	199
2014 Q2	$1.11M	Sell	32,172 -3,400	-10%	-$107K	0.1%	206
2014 Q1	$1.54M	Buy	+35,572	New	+$1.72M	0.13%	188

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Wall Street Associates's IONS Position: Q3 2015 in Review

Wall Street Associates sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 21,850 shares — an estimated $1.26M sold.

Wall Street Associates first reported a position in IONS in Q1 2014 and held it in 6 quarters. The position peaked at $2.46M in Q4 2014. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

Wall Street Associates reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Wall Street Associates sold 21,850 Ionis Pharmaceuticals shares in Q3 2015, an estimated $1.26M.
Wall Street Associates first reported a position in Ionis Pharmaceuticals in Q1 2014 and held it in 6 quarters.
Wall Street Associates's Ionis Pharmaceuticals position peaked at $2.46M in Q4 2014.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.